AMPLIVAX IR103

· Immune Response BioPharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMPLIVAX IR103, covering 2016-02-23 to 2016-02-23. Get the full timeline:

Most recent: Clinical Trial Update: REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study [Phase 3]